Anti-HIV Agents

"Anti-HIV Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Descriptor ID	D019380
MeSH Number(s)	D27.505.954.122.388.077.088
Concept/Terms	Anti-HIV Agents Anti-HIV Agents Agents, Anti-HIV Anti HIV Agents Anti-AIDS Agents Agents, Anti-AIDS Anti AIDS Agents Anti-HIV Drugs Anti HIV Drugs Drugs, Anti-HIV AIDS Drugs Drugs, AIDS Anti-AIDS Drugs Anti AIDS Drugs Drugs, Anti-AIDS

Below are MeSH descriptors whose meaning is more general than "Anti-HIV Agents".

Chemicals and Drugs [D]
Chemical Actions and Uses [D27]
Pharmacologic Actions [D27.505]
Therapeutic Uses [D27.505.954]
Anti-Infective Agents [D27.505.954.122]
Antiviral Agents [D27.505.954.122.388]
Anti-Retroviral Agents [D27.505.954.122.388.077]
Anti-HIV Agents [D27.505.954.122.388.077.088]

Below are MeSH descriptors whose meaning is related to "Anti-HIV Agents".

Below are MeSH descriptors whose meaning is more specific than "Anti-HIV Agents".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Anti-HIV Agents" by people in this website by year, and whether "Anti-HIV Agents" was a major or minor topic of these publications.

Bar chart showing 313 publications over 29 distinct years, with a maximum of 23 publications in 2017 and 2020

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1997	1	1	2
1998	2	1	3
2000	0	1	1
2001	0	3	3
2002	2	2	4
2003	5	4	9
2004	6	3	9
2005	2	6	8
2006	4	3	7
2007	8	5	13
2008	4	1	5
2009	3	1	4
2010	9	1	10
2011	7	4	11
2012	10	3	13
2013	9	6	15
2014	10	2	12
2015	13	3	16
2016	15	3	18
2017	19	4	23
2018	8	9	17
2019	11	5	16
2020	16	7	23
2021	15	5	20
2022	8	0	8
2023	6	0	6
2024	6	8	14
2025	14	4	18
2026	3	2	5

Below are the most recent publications written about "Anti-HIV Agents" by people in Profiles.

van Wees DA, Sarink D, van Benthem BHB, Kampman K, van Bokhoven C, van Aar F. Lost and Not Found: Determinants and Patterns of Loss to Follow-Up Among Men Who Have Sex With Men in the Dutch HIV Pre-Exposure Prophylaxis Pilot Program. J Acquir Immune Defic Syndr. 2026 May 01; 101(5):455-463.

View in: PubMed
Sophus AI, Mitchell JW, Mangum L, Fuentes JF, Collins S, Gamble-George J, Hill MJ, Stockman JK, Dubov A. Preferences for PrEP program attributes among Black women aged ?45 in the US South: A secondary analysis using discrete choice experiment. Womens Health (Lond). 2026 Jan-Dec; 22:17455057261437288.

View in: PubMed
Aidoo-Frimpong G, Mangum LC, Sophus AI, Gray A, Hill MJ. Awareness, Acceptability, and Preferences for Pre-exposure Prophylaxis Modalities Among Black Women: A Critical Review and Brief Report of a Pilot Study. AIDS Educ Prev. 2026 Apr; 38(2):135-150.

View in: PubMed
Khanna A, Lee F, Schrode K, Sheeler D, Hotton A, Schneider J, Fujimoto K, Chirumamilla S, Kwa Sey E, Harawa NT. Brief Report: Long-Acting Injectable PrEP Can Substantially Reduce HIV Incidence in Los Angeles County: A Simulation Study. J Acquir Immune Defic Syndr. 2026 Mar 01; 101(3):273-278.

View in: PubMed
Van Dyke RB, Sawyer GW, Williams PL, Yu W, Mendez AJ, Gerschenson M, Attia EF, Lipshultz SE. Longitudinal assessment of inflammatory biomarkers among youth with perinatal HIV infection and HIV exposure. AIDS. 2026 Jun 01; 40(6):753-762.

View in: PubMed
Madlala HP, Jao J, Roussos G, Mendham AE, Myer L, Abrams E, Geffen H, Mukonda E, Modibedi R, Odayar J, Matyesini S, Dugas LR, Goedecke JH, Catalano P, McComsey GA, Gerschenson M. Gluteal Adipose Tissue Mitochondrial Respiration and Insulin Sensitivity in Pregnant South African Women Living With HIV on Tenofovir-Lamivudine-Dolutegravir. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):462-470.

View in: PubMed
Shangani S, Sharma AR, Shourya S, Assoumou SA, Sales JM, Rodriguez-Diaz CE. Pre-Exposure Prophylaxis Cascade Outcomes Among Black Cisgender Women in the Southern United States. AIDS Patient Care STDS. 2026 Feb; 40(2):68-77.

View in: PubMed
Ndhlovu LC, Giron LB, Galinskas J, Premeaux TA, Pang APS, Dias D, de Almeida Baptista MV, Shytaj IL, Maricato JT, Ferreira PRA, Gosuen G, Corley MJ, Friday CM, Bowler SA, Della Libera E, Sucupira MC, Hunter JR, Janini LM, Schechter M, Savarino A, Diaz RS. Virological and Immunological Outcomes of Combined Therapeutic Interventions and Dendritic Cell Therapy in People With HIV. J Infect Dis. 2025 Nov 14; 232(5):1067-1077.

View in: PubMed
Morehead-Gee A, Selders D, Hill K, Chavez A, Gonzalez J, Takata L, Nazarian J, Mosqueda D. Pharmacy HIV pre-exposure prophylaxis/post-exposure prophylaxis furnishing: The benefits of collaborating with peer navigators. J Am Pharm Assoc (2003). 2026 Jan-Feb; 66(1):102978.

View in: PubMed
Ghanooni D, Heise MJ, Sassaman K, Glidden DV, Martinson T, Mahuvakar S, Duncan DT, Horvath KJ, Hirshfield S, Williams R, Johnson MO, Grov C, Gandhi M, Carrico AW, Spinelli M. Suboptimal ART adherence, undetectable urine tenofovir, and higher C-reactive protein values. AIDS. 2025 Nov 01; 39(13):1975-1978.

View in: PubMed

People

Explore

Similar Concepts

Top Journals